Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A12 | P48065 | 5/20 | 0.38 |
| ▸ | SLC6A11 | P48066 | 5/20 | 0.38 |
| ▸ | SLC6A13 | Q9NSD5 | 5/20 | 0.38 |
| ▸ | SUCNR1 | Q9BXA5 | 2/20 | 0.35 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.35 |
| ▸ | LDHA | P00338 | 1/20 | 0.33 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.33 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.33 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.33 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.33 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.33 |
| ▸ | ITGAV | P06756 | 1/20 | 0.33 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.33 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.33 |
| ▸ | ITGB5 | P18084 | 1/20 | 0.33 |
| ▸ | ITGAL | P20701 | 1/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.32 |
| ▸ | SLC6A1 | P30531 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28655709 | 1.00 | SLC6A12 (0.38) | SLC6A12SLC6A11SLC6A13SUCNR1HSD11B1 | |
| SCHEMBL10477587 | 0.97 | SLC6A12 (0.36) | SLC6A12SLC6A11SLC6A13SUCNR1HSD11B1 | |
| SCHEMBL11698166 | 0.89 | — | — | |
| SCHEMBL5413833 | 0.87 | — | — | |
| SCHEMBL3062281 | 0.87 | — | — | |
| SCHEMBL5413831 | 0.87 | — | — | |
| SCHEMBL747060 | 0.84 | IGF2R (0.39) | SLC6A12SLC6A11SLC6A13SUCNR1LMNA | |
| SCHEMBL28821679 | 0.83 | KAT2A (0.38) | TSHRFFAR3OR51E2 | |
| SCHEMBL3259081 | 0.81 | MAPT (0.33) | — | |
| SCHEMBL1252905 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102796261-A | Polyamine derivative, as well as preparation method and application thereof | GUANGZHOU XINGYE TECHNOLOGY CO LTD | 2012-11-28 | — | — | CN | claimed |
| CN-102796627-A | Washing composition | GUANGZHOU STARTEC SCIENCE & TECHNOLOGY CO LTD | 2012-11-28 | — | — | CN | claimed |
| US-20090274741-A1 | POLYMERS CONTAINING POLY(ESTER AMIDES) AND AGENTS FOR USE WITH MEDICAL ARTICLES AND METHODS OF FABRICATING THE SAME | ADVANCED CARDIOVASCULAR SYSTEMS, INC. | 2009-11-05 | — | — | US | claimed |
| JP-2008500430-A | — | — | 2008-01-10 | — | — | JP | claimed |
| EP-1828281-A2 | POLYMERS CONTAINING POLY(ESTER AMIDES) AND AGENTS FOR USE WITH MEDICAL ARTICLES AND METHODS OF FABRICATING THE SAME | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2007-09-05 | — | — | EP | claimed |
| WO-2005118681-A2 | POLYMERS CONTAINING POLY(ESTER AMIDES) AND AGENTS FOR USE WITH MEDICAL ARTICLES AND METHODS OF FABRICATING THE SAME | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2005-12-15 | — | — | WO | claimed |
| US-20050265960-A1 | Polymers containing poly(ester amides) and agents for use with medical articles and methods of fabricating the same | ADVANCED CARDIOVASCULAR SYSTEMS, INC. | 2005-12-01 | — | — | US | claimed |
| US-5147791-A | Reacting diester and dialcohol in presence of enzyme catalyst;enantiomorphs | UNIVERSITY OF NEW MEXICO (US) | 1992-09-15 | — | — | US | claimed |
| JP-54043297-A | — | — | None | — | — | JP | disclosed |
| US-9603943-B2 | Polyesteramide platform for site specific drug delivery | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2017-03-28 | — | — | US | disclosed |
| US-20150290336-A1 | POLYESTERAMIDE PLATFORM FOR SITE SPECIFIC DRUG DELIVERY | ABBOTT CARDIOVASCULAR SYSTEMS (US) | 2015-10-15 | — | — | US | disclosed |
| US-9095619-B2 | Polyesteramide platform for site specific drug delivery | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2015-08-04 | — | — | US | disclosed |
| US-20150010491-A1 | POLYESTERAMIDE PLATFORM FOR SITE SPECIFIC DRUG DELIVERY | ABBOTT CARDIOVASCULAR SYSTEMS (US) | 2015-01-08 | — | — | US | disclosed |
| US-8865148-B2 | Polyesteramide platform for site specific drug delivery | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2014-10-21 | — | — | US | disclosed |
| US-20060111546-A1 | Biologically absorbable coatings for implantable devices based on polyesters and methods for fabricating the same | ADVANCED CARDIOVASCULAR SYSTEMS, INC. | 2006-05-25 | — | — | US | disclosed |
| US-20050288481-A1 | Design of poly(ester amides) for the control of agent-release from polymeric compositions | ADVANCED CARDIOVASCULAR SYSTEMS, INC. | 2005-12-29 | — | — | US | disclosed |
| WO-2005118681-A2 | POLYMERS CONTAINING POLY(ESTER AMIDES) AND AGENTS FOR USE WITH MEDICAL ARTICLES AND METHODS OF FABRICATING THE SAME | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2005-12-15 | — | — | WO | disclosed |
| US-20050265960-A1 | Polymers containing poly(ester amides) and agents for use with medical articles and methods of fabricating the same | ADVANCED CARDIOVASCULAR SYSTEMS, INC. | 2005-12-01 | — | — | US | disclosed |
| CN-1454930-A | Polyester composition | EASTMAN CHEM CO (US) | 2003-11-12 | — | — | CN | disclosed |
| JP-S5443297-A | PROCUCTION OF EPOXY GROUP-CONTAINING POLYAMIDE | JAPAN SYNTHETIC RUBBER CO LTD | 1979-04-05 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150010491-A1 | POLYESTERAMIDE PLATFORM FOR SITE SPECIFIC DRUG DELIVERY | CES2, KIT, NAAA | SLC6A12 1877/4885SLC6A11 1770/4885SLC6A13 1922/4885 |
| US-20090274741-A1 | POLYMERS CONTAINING POLY(ESTER AMIDES) AND AGENTS FOR USE WITH MEDICAL ARTICLES AND METHODS OF FABRICATING THE SAME | BCAT2, PAM, BCAT1 | SLC6A12 1684/4885SLC6A11 1125/4885SLC6A13 909/4885 |
| US-20050265960-A1 | Polymers containing poly(ester amides) and agents for use with medical articles and methods of fabricating the same | BCAT2, PAM, BCAT1 | SLC6A12 1684/4885SLC6A11 1125/4885SLC6A13 909/4885 |
| US-20150290336-A1 | POLYESTERAMIDE PLATFORM FOR SITE SPECIFIC DRUG DELIVERY | CES2, KIT, NAAA | SLC6A12 1877/4885SLC6A11 1770/4885SLC6A13 1922/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.